Philip Meier

ImageBiopsy Lab (IB Lab) is an international Health-AI Startup aiming to challenge the Status Quo of radiographic image analysis. We address insufficient, subjective grading and lacking standardization in the assessment and early prediction of osteoarthritis, osteoporosis and rheumatoid arthritis. Due to the lack of objective analyses methods and standardized digital documentation of radiographic changes, disease diagnosis and predictive assumptions are time consuming and often unreliable

• Build excellent customer relations with key physicians, hospital personnel, and authorized distributors, as well as conduct customer education seminars as appropriate • Consulting doctors on minimally invasive and open surgical instruments • Including sutures, surgical staplers, clip appliers, trocars, energy devices and haemostats • Specialties include support for treatment of colorectal and thoracic conditions, women's health conditions, hernias, cancer and obesity

• Key role in acquisition and engaging with the right set of restaurants • Manage end-to-end client relationship • Establishing long term partnerships with restaurants and businesses • B2B sales and understanding of sales ecosystem • Field intensive and performance based • Outstanding track record

• Master courses included: o Small molecule drug discovery o Drug Metabolism and Toxicology o Molecular Pharmacology o Bio-business and commercialisation of Bioscience research
 • Research Project: Validation and optimisation of a new transfection reagent

• Research project on: The effects of zinc deficiency on blood vessel and platelet function